Germany Digital Pathology Market Top Key players are Visiopharm, Digipath Inc. Koninklinje Philips N. V., PerkinElmer,Danaher Corporation

German Digital Pathology Market Report, published by Allied Market Research, forecasts that the market is expected to garner $58 million by 2022, registering a CAGR of 12.1% during the period 2016 - 2022.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/1724

Digital Pathology (DP) is an emerging technology in the pathology field, where glass slides are converted into digital images for easy viewing, analysis, storage, and management of the data collected. This advancement will also bring about upgradation of conventional pathology. Thus, the shortage in number of pathologists around the world is addressed by the use of digital pathology, which is the major benefit of this technology.
Need for cost reduction in laboratories, demand for improved patient care, and enhanced operational efficiency is driving the German digital pathology market. Furthermore, accuracy, ease in remote pathological testing along with acceptability from pathologists and laboratories are other factors that majorly drive this market. However, inadequate infrastructure, lack of reimbursement policies and pending market approvals restrain the market growth.

The digital pathology market is segmented based on product, namely whole slide imaging (WSI), image analysis informatics, information management system storage & communication and telepathology. The whole slide imaging (WSI) segment is the highest revenue-generating market among the segments, due to the capability of WSI to convert glass slides into digital slides and making the study of slides convenient for pathologists. This makes it easier for the pathologist to deliver them easily to other pathologist with reduced cost and without any damage. Furthermore, Information Management System Storage & Communication market is expected to grow by 2022; mainly due to the increase in technological advancement in the integration process and storage process.

The end user segment of the digital pathology market is segmented into educational institutes, hospitals & diagnostic centers, and pharmaceutical & biotechnology companies. Hospitals & diagnostic centers was the highest revenue-generating market as compared to the other segments. The market is expected to grow at a significant rate due to the increase in the use of DPS for drug development and discovery.

For More Details: https://www.alliedmarketresearch.com/germany-digital-pathology-market

Pharmaceutical & biotechnology companies was the second highest revenue-generating segment due to the increase in use of DPS in the diagnosis sectors such as cancer diagnosis. Educational institutes had the lowest revenue among all the segments. This low market share can be attributed to the low use of DPS in the educational institutes as it has very limited adoption, due to the expenses involved in its setup.

Recent developments such as product launch of GeminiSEM 300 system by Carl Zeiss, partnership between Glencoe Software and Carl Zeiss to cover the open source Bio-Formats and product development of CD15 Quantifier by VMscope further signify the increase in competition in the German digital pathology industry. These developments are majorly focused on manufacturing digital pathology instruments, thereby positively increasing the market revenue as well as a healthy rivalry among the manufacturers.

Key Findings of the Germany Digital Pathology Market:
o Whole slide imaging is expected to grow significantly by 2022 at a CAGR of 9.5%.
o Information Management System Storage & Communication is expected to be the second highest growing segment, and would grow at CAGR 11.6% during the forecast period.
o Educational Institutes and Hospitals and diagnostic centers together accounted for over one-third share of the total German digital pathology market.
o Pharmaceutical & biotechnology companies is expected to be the highest growing market by end user; growing at a significant CAGR of 14.4% during 2016 to 2022.

The key players in the German digital pathology market focus to expand their business operations in emerging countries with product launch as their preferred strategy. Major players profiled in this report include Visiopharm, Digipath Inc., Koninklinje Philips N. V., PerkinElmer, Inc., Danaher Corporation (Leica Microsystem), Nikon Corporation, Carl Zeiss AG, Definiens AG, VMscope GmbH, and microDimensions GmbH.

Related Reports:
Hormone Refractory Prostate Cancer (HRPCA) Market
https://www.alliedmarketresearch.com/hormone-refractory-prostate-cancer-market

Antibacterial Therapeutic Market
https://www.alliedmarketresearch.com/antibacterial-therapeutic-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.